AMARIN
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials. These trials are investigating the efficacy of AMR101 in lowering triglycerides in patients with very high triglycerides (>500mg/dl) and in patients with mixed dyslipidemia who are taking statins. Amarin’s cardiovascular programs capitalize on Amarin'... s expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in treating cardiovascular disease. Amarin is headquartered in Dublin, Ireland, and has its research and development headquartered in Mystic Connecticut, USA. Amarin is listed in the U.S. on NASDAQ (ticker: AMRN)
AMARIN
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
1991-01-01
Address:
Ballsbridge, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.amarincorp.com
Total Employee:
101+
Status:
Active
Contact:
+353 1 669 9020
Email Addresses:
[email protected]
Total Funding:
227.82 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Tag Manager LetsEncrypt Cloudflare Hosting Apache Cloudflare JS CDN JS Pound Sterling
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
CureVac
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sparrow Pharmaceuticals
Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2007-12-05 | Ester Neurosciences | Ester Neurosciences acquired by Amarin | N/A |
Investors List
Abingworth
Abingworth investment in Post-IPO Equity - Amarin
Fountain Healthcare Partners
Fountain Healthcare Partners investment in Post-IPO Equity - Amarin
OrbiMed
OrbiMed investment in Post-IPO Equity - Amarin
Longitude Capital
Longitude Capital investment in Post-IPO Equity - Amarin
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - Amarin
Newest Events participated
Participated in 12th Annual Cardiometabolic Health Congress
on 2017-10-04 as exhibitor
Key Employee Changes
Official Site Inspections
http://www.amarincorp.com Semrush global rank: 3.41 M Semrush visits lastest month: 4.03 K
- Host name: 172.66.137.240
- IP address: 172.66.137.240
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amarin"
Amarin Corporation - Wikipedia
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. See details»
Amarin Corporation - LinkedIn
Amarin Corporation | 32,329 followers on LinkedIn. Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. | Amarin is an innovative ...See details»
Amarin Company Profile - Office Locations, Competitors, Revenue …
Oct 29, 2024 Amarin has 5 employees across 3 locations and $306.91 m in annual revenue in FY 2023. See insights on Amarin including office locations, competitors, revenue, financials, …See details»
Amarin - Crunchbase Company Profile & Funding
Amarin Corporation is a clinical-stage biopharmaceutical company focused on improving the treatment of cardiovascular disease. Amarin’s lead candidate, AMR101, is currently being studied in two concurrently run pivotal Phase 3 trials.See details»
Amarin Corporation - Overview, News & Similar companies
Jun 3, 2024 Amarin Corporation contact info: Phone number: +353 16699020 Website: www.amarincorp.com What does Amarin Corporation do? Founded in 1991, Amarin …See details»
Amarin Implements Organizational Restructuring to
Jul 18, 2023 The conference call can be accessed on the investor relations section of the Company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»
Amarin Implements Organizational Restructuring to Strengthen …
Jul 18, 2023 Amarin Corporation plc-- Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources ---- Maximizes Cash …See details»
Amarin Pharma - Crunchbase Company Profile
Amarin Pharma is a pharmaceutical manufacturing. They creates a new paradigm in cardiovascular disease management and is positioned to address cardiovascular risk for millions of patients globally.See details»
Amarin Implements Organizational Restructuring to Strengthen …
Jul 18, 2023 The conference call can be accessed on the investor relations section of the Company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»
AMARIN IMPLEMENTS ORGANIZATIONAL RESTRUCTURING TO …
Jul 19, 2023 Amarin's refocused strategic priorities and restructuring plan focuses on three core areas: Maximizing U.S. Cash Flow Through Streamlined Model: Amarin will maintain …See details»
Amarin Names Aaron Berg Interim President & Chief Executive …
Apr 17, 2023 DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of …See details»
Amarin Names Aaron Berg Interim President & Chief Executive …
Apr 17, 2023 DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that the Company’s Board of …See details»
Amarin Reports Second Quarter 2024 Financial Results and …
Jul 31, 2024 DUBLIN and BRIDGEWATER, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today reported financial results for the second quarter …See details»
Amarin Mails Letter to Shareholders Highlighting New Board
Feb 2, 2023 Chairman of Oncopeptides – built and downsized the Company’s U.S. organization over 12 months, following the loss of continued commercialization opportunity ...See details»
Amarin Corporation plc (AMRN) Price & News - Google Finance
Get the latest Amarin Corporation plc (AMRN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.See details»
Amarin to Report Fourth Quarter and Full Year 2023 Financial …
Feb 15, 2024 Go to the investor relations section of the Company's website at www.amarincorp.com Dial in within the United States: 888-506-0062 International dial in: 973 …See details»
Amarin Reports First Quarter 2022 Financial Results and
May 4, 2022 The conference call can be accessed on the investor relations section of the company's website at www.amarincorp.com, or via telephone by dialing 888-506-0062 within …See details»
Amarin Reports Fourth Quarter and Full Year 2023 Financial …
Feb 29, 2024 Amarin Corporation plc-- Company Delivers Total Revenues of $75 Million in the Fourth Quarter and $306 Million for the Full-Year 2023 ---- Reaffirms Year-End 2023 Cash …See details»
Amarin Reports Third Quarter 2023 Financial Results - Yahoo Finance
Nov 1, 2023 Amarin Corporation plc-- Company Reported Total Net Revenues of $66 Million in the Third Quarter 2023 ---- Delivered Positive Cash Flow of $8 Million in the Quarter, Marking …See details»